Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 731462, 9 pages
http://dx.doi.org/10.1155/2014/731462
Research Article

Possible Potentiation by Certain Antioxidants of the Anti-Inflammatory Effects of Diclofenac in Rats

1Department of Pharmacology and Toxicology, Misr International University (MIU), Km 28, Cairo-Ismailia Road, P.O. Box 1, Heliopolis, Cairo, Egypt
2Department of Biochemistry, Faculty of Pharmacy, Misr International University (MIU), Km 28, Cairo-Ismailia Road, P.O. Box 1, Heliopolis, Cairo, Egypt
3Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt

Received 30 August 2013; Accepted 22 January 2014; Published 12 March 2014

Academic Editors: P. Campiglia, G. Iaccarino, M. Illario, and N. Montuori

Copyright © 2014 Samah S. Abbas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Gabay, “Interleukin-6 and chronic inflammation,” Arthritis Research and Therapy, vol. 8, supplement 2, article S3, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. M. Peake, K. Suzuki, and J. S. Coombes, “The influence of antioxidant supplementation on markers of inflammation and the relationship to oxidative stress after exercise,” Journal of Nutritional Biochemistry, vol. 18, no. 6, pp. 357–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. N. A. El-Shitany, S. A. El-Masry, M. A. El-Ghareib, and K. El-Desoky, “Thioctic acid protects against carrageenan-induced acute inflammation in rats by reduction in oxidative stress, downregulation of COX-2 mRNA and enhancement of IL-10 mRNA,” Fundamental and Clinical Pharmacology, vol. 24, no. 1, pp. 91–99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. D. Deore, A. K. Srivastava, and S. K. Sharma, “Effect of reduced glutathione treatment on selenosis, blood selenium concentration and glutathione peroxidase activity after repeated short-term selenium exposure in buffalo calves,” Toxicology, vol. 213, no. 1-2, pp. 169–174, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Sakai, T. Hirano, R. Okazaki, N. Okimoto, K. Tanaka, and T. Nakamura, “Large-dose ascorbic acid administration suppresses the development of arthritis in adjuvant-injected rats,” Archives of Orthopaedic and Trauma Surgery, vol. 119, no. 3-4, pp. 121–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Y. Liu, C. C. Chen, C. L. Chen, and C. W. Chi, “Safrole-induced oxidative damage in the liver of Sprague-Dawley rats,” Food and Chemical Toxicology, vol. 37, no. 7, pp. 697–702, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Abou-Mohamed, H. A. El-Kashef, H. A. Salem, and M. M. Elmazar, “Effect of zinc an the anti-inflammatory and ulcerogenic activities of indometacin and diclofenac,” Pharmacology, vol. 50, no. 4, pp. 266–272, 1995. View at Google Scholar · View at Scopus
  8. M. Uchiyama and M. Mihara, “Determination of malonaldehyde precursor in tissues by thiobarbituric acid test,” Analytical Biochemistry, vol. 86, no. 1, pp. 271–278, 1978. View at Google Scholar · View at Scopus
  9. S. Marklund and G. Marklund, “Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase,” European Journal of Biochemistry, vol. 47, no. 3, pp. 469–474, 1974. View at Google Scholar · View at Scopus
  10. “International Committee for Standardization in Haematology,” British Journal of Haematology, vol. 13, pp. 68–70, 1967.
  11. E. Beutler, O. Duron, and B. M. Kelly, “Improved method for the determination of blood glutathione,” The Journal of Laboratory and Clinical Medicine, vol. 61, pp. 882–888, 1963. View at Google Scholar · View at Scopus
  12. F. Odabasoglu, Z. Halici, A. Cakir et al., “Beneficial effects of vegetable oils (corn, olive and sunflower oils) and α-tocopherol on anti-inflammatory and gastrointestinal profiles of indomethacin in rats,” European Journal of Pharmacology, vol. 591, no. 1–3, pp. 300–306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. T. Khayyal, M. A. El-Ghazaly, R. M. El-Hazek, and A. S. Nada, “The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats,” Inflammopharmacology, vol. 17, no. 5, pp. 255–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J.-H. Shang, X.-H. Cai, T. Feng et al., “Pharmacological evaluation of Alstonia scholaris: anti-inflammatory and analgesic effects,” Journal of Ethnopharmacology, vol. 129, no. 2, pp. 174–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Tastekin, N. Aydogdu, D. Dokmeci et al., “Protective effects of l-carnitine and alpha-lipoic acid in rats with adjuvant arthritis,” Pharmacological Research, vol. 56, no. 4, pp. 303–310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A.-R. M. A. Meki, E. A. Hamed, and K. A. Ezam, “Effect of green tea extract and vitamin C on oxidant or antioxidant status of rheumatoid arthritis rat model,” Indian Journal of Clinical Biochemistry, vol. 24, no. 3, pp. 280–287, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. M. Tessier, A. Khalil, L. Trottier, and T. Fülöp, “Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes,” Archives of Gerontology and Geriatrics, vol. 48, no. 1, pp. 67–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Gabrashanska, S. E. Teodorova, S. Petkova, L. Mihov, M. Anisimova, and D. Ivanov, “Selenium supplementation at low doses contributes to the antioxidant status in Trichinella spiralis-infected rats,” Parasitology Research, vol. 106, no. 3, pp. 561–570, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. M. B. Pepys and M. L. Baltz, “Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein,” Advances in Immunology, vol. 34, pp. 141–212, 1983. View at Google Scholar · View at Scopus
  20. A. J. Szalai, F. W. van Ginkel, S. A. Dalrymple, R. Murray, J. R. McGhee, and J. E. Volanakis, “Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice,” Journal of Immunology, vol. 160, no. 11, pp. 5294–5299, 1998. View at Google Scholar · View at Scopus
  21. S. A. Jones, D. Novick, S. Horiuchi, N. Yamamoto, A. J. Szalai, and G. M. Fuller, “C-reactive protein: a physiological activator of interleukin 6 receptor shedding,” Journal of Experimental Medicine, vol. 189, no. 3, pp. 599–604, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Kyriakou, H. Papadaki, A. G. Eliopoulos, A. Foudoulakis, M. Alexandrakis, and G. D. Eliopoulos, “Serum soluble IL-6 receptor concentrations correlate with stages of multiple myeloma defined by serum β2-microglobulin and C-reactive protein,” International Journal of Hematology, vol. 66, no. 3, pp. 367–371, 1997. View at Google Scholar · View at Scopus
  23. Y. Oka, T. Ibuki, K. Matsumura et al., “Interleukin-6 is a candidate molecule that transmits inflammatory information to the CNS,” Neuroscience, vol. 145, no. 2, pp. 530–538, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Cicala, S. Morello, A. Alfieri, V. Vellecco, S. Marzocco, and G. Autore, “Haemostatic imbalance following carrageenan-induced rat paw oedema,” European Journal of Pharmacology, vol. 577, no. 1–3, pp. 156–161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. N. L. Vajja, S. Juluri, M. Kumari, L. Kole, R. Chakrabarti, and V. D. Joshi, “Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents,” International Immunopharmacology, vol. 4, no. 7, pp. 901–909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Greis, J. Murgott, S. Rafalzik, R. Gerstberger, T. Hübschle, and J. Roth, “Characterization of the febrile response induced by fibroblast-stimulating lipopeptide-1 in guinea pigs,” American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 293, no. 1, pp. R152–R161, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Cruz, J. D. Quintana-Hau, J. R. González, R. Tornero-Montaño, L. M. Baiza-Durán, and L. Vega, “Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation,” British Journal of Ophthalmology, vol. 92, no. 1, pp. 120–125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. L. Dugina, V. I. Petrov, A. R. Babayeva et al., “A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-α and diclofenac in rheumatoid arthritis,” International Journal of Tissue Reactions, vol. 27, no. 1, pp. 15–21, 2005. View at Google Scholar · View at Scopus
  29. J. A. Schleining, S. R. McClure, R. B. Evans, W. G. Hyde, L. W. Wulf, and A. J. Kind, “Liposome-based diclofenac for the treatment of inflammation in an acute synovitis model in horses,” Journal of Veterinary Pharmacology and Therapeutics, vol. 31, no. 6, pp. 554–561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. S. N. Han, D. Wu, W. K. Ha et al., “Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus,” Immunology, vol. 100, no. 4, pp. 487–493, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. O. Adolfsson, B. T. Huber, and S. N. Meydani, “Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity,” Journal of Immunology, vol. 167, no. 7, pp. 3809–3817, 2001. View at Google Scholar · View at Scopus
  32. J. Filep and E. Foldes-Filep, “Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor,” Life Sciences, vol. 44, no. 8, pp. 517–524, 1989. View at Google Scholar · View at Scopus
  33. R. R. Kew, T. M. Hyers, and R. O. Webster, “Human C-reactive protein inhibits neutrophil chemotaxis in vitro: possible implications for the adult respiratory distress syndrome,” Journal of Laboratory and Clinical Medicine, vol. 115, no. 3, pp. 339–345, 1990. View at Google Scholar · View at Scopus
  34. R. M. Heuertz, C. A. Piquette, and R. O. Webster, “Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis,” American Journal of Pathology, vol. 142, no. 1, pp. 319–328, 1993. View at Google Scholar · View at Scopus
  35. N. Ahmed, R. Thorley, D. Xia, D. Samols, and R. O. Webster, “Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 3, pp. 1141–1147, 1996. View at Google Scholar · View at Scopus
  36. A. J. Szalai, A. Agrawal, T. J. Greenhough, and J. E. Volanakis, “C-reactive protein. Structural biology, gene expression, and host defense function,” Immunologic Research, vol. 16, no. 2, pp. 127–136, 1997. View at Google Scholar · View at Scopus
  37. C. Zouki, M. Beauchamp, C. Baron, and J. G. Filep, “Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C- reactive protein,” Journal of Clinical Investigation, vol. 100, no. 3, pp. 522–529, 1997. View at Google Scholar · View at Scopus
  38. M. Yamamoto, K. Yoshizaki, T. Kishimoto, and H. Ito, “IL-6 is required for the development of Th1 cell-mediated murine colitis,” Journal of Immunology, vol. 164, no. 9, pp. 4878–4882, 2000. View at Google Scholar · View at Scopus
  39. Z. Xing, J. Gauldie, G. Cox et al., “IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses,” Journal of Clinical Investigation, vol. 101, no. 2, pp. 311–320, 1998. View at Google Scholar · View at Scopus
  40. J. van Snick, “Interleukin-6: an overview,” Annual Review of Immunology, vol. 8, pp. 253–278, 1990. View at Google Scholar · View at Scopus
  41. A. Vink, C. Uyttenhove, P. Wauters, and J. van Snick, “Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor,” European Journal of Immunology, vol. 20, no. 1, pp. 1–6, 1990. View at Google Scholar · View at Scopus
  42. P. H. Canter, B. Wider, and E. Ernst, “The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials,” Rheumatology, vol. 46, no. 8, pp. 1223–1233, 2007. View at Publisher · View at Google Scholar · View at Scopus